1. World Health Organization Global tuberculosis report 2013 http://www.who.int/tb/publications/global_report/en/index.html
2. Centers for Disease Control and Prevention Antibiotic resistance threats in the United States, 2013 Atlanta CDC 2013 http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf
3. Centers for Disease Control and Prevention Provisional CDC Guidelines for the Use and Safety Monitoring of Bedaquiline Fumarate (Sirturo) for the Treatment of Multidrug-Resistant Tuberculosis
4. World Health Organization The use of bedaquiline in the treatment of multidrug-resistant tuberculosis Interim policy guidance http://apps.who.int/iris/bitstream/10665/84879/1/9789241505482_eng.pdf?ua=1
5. TMC207: the first compound of a new class of potent anti-tuberculosis drugs;Matteelli;Future Microbiol,2010